The new Canadian guideline presents evidence-based recommendations for prescribing of opioids for chronic non-cancer pain, including maximum dose recommendations, avoiding opioids in high-risk populations, and guidance for tapering.
, Associate Professor in the Department of Anesthesia at McMaster University and researcher with the Michael G. DeGroote National Pain Centre in Hamilton, Ontario, co-authored the (open access). In this podcast, he speaks with Dr. Diane Kelsall, interim editor-in-chief, CMAJ, and explains the recommendations.
Listen to the author interview:
Dr. Matthew Stanbrook, deputy editor of CMAJ, interviews , family physician and VP of Medical Affairs and Health System Solutions at Women's College Hospital in Toronto (and she made headlines last year when she eloquently in front of the US Senate during the Obamacare debate).
Dr. Martin and co-authors (, , , ) say that implementing universal public coverage of prescription drugs in Canada would be estimated to reduce total spending by $7.2 billion while increasing government costs by only $1.0 billion. This economic modeling study shows that universal public drug coverage could be implemented without substantially increasing government spending.
Subscribe to CMAJ Podcasts on , , Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our. Our podcasts are also released on and here on the blogs.